Lori M. Henderson - May 25, 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
General Counsel and Secretary
Signature
/s/ Brian Sandstrom, as Attorney-in-Fact
Stock symbol
MRNA
Transactions as of
May 25, 2021
Transactions value $
-$1,001,418
Form type
4
Date filed
5/27/2021, 04:04 PM
Previous filing
May 21, 2021
Next filing
May 28, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise $98K +6.6K +732.52% $14.85* 7.5K May 25, 2021 Direct F1
transaction MRNA Common Stock Sale -$1.1M -6.6K -87.99% $166.58 901 May 25, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -6.6K -1.93% $0.00 335K May 25, 2021 Common Stock 6.6K $14.85 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2020.
F2 25% of this option will vest and become exercisable on April 9, 2019 with the remainder vesting in 12 equal quarterly installments thereafter.